[company_age]40.0[/company_age][employees]10,001+ employees[/employees][description]Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, the company is committed to providing access to affordable and innovative medicines. Driven by its purpose of 'Good Health Can't Wait', Dr. Reddy's offers a portfolio of products and services including APIs, generics, branded generics, biosimilars, and OTC. The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy's major markets include the USA, India, Russia & CIS countries, China, Brazil, and Europe. The company has a history of deep science that has led to several industry firsts, and it continues to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, Dr. Reddy's released its first Sustainability Report in 2004. The company's current ESG goals aim to set the bar high in environmental stewardship, access and affordability for patients, diversity, and governance.[/description][ps]APIs, generics, branded generics, biosimilars, and OTC[/ps]